Correct ToneO - IML wrote this in a recent QVE update (a LIC they manage) "Mayne Pharma fell fairlyheavily after announcing a weaker than expected earnings outlook for the second half of FY19 for its US generics business. We believe that Mayne’s sharesremain very undervalued. While the generics business remains volatile, investors appear to be ignoring the continued strong growth in the company’scontract services and branded pharma divisions, which will soon represent a total of 50% of group EBIT. "
Correct ToneO - IML wrote this in a recent QVE update (a LIC...
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.86 |
Change
-0.170(4.22%) |
Mkt cap ! $325.8M | |||
| Open | High | Low | Value | Volume |
| $4.00 | $4.00 | $3.82 | $287.4K | 73.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1078 | $3.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.86 | 374 | 6 |
View Market Depth
| Last trade - 11.51am 05/08/2024 (20 minute delay) ? |
| MYX (ASX) Chart |